company background image
RSLB.F logo

RaySearch Laboratories OTCPK:RSLB.F Stock Report

Last Price

US$15.62

Market Cap

US$511.7m

7D

0%

1Y

95.3%

Updated

04 Oct, 2024

Data

Company Financials +

RaySearch Laboratories AB (publ)

OTCPK:RSLB.F Stock Report

Market Cap: US$511.7m

RSLB.F Stock Overview

A medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East.

RSLB.F fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance5/6
Financial Health6/6
Dividends0/6

RaySearch Laboratories AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RaySearch Laboratories
Historical stock prices
Current Share PriceSEK 15.62
52 Week HighSEK 15.62
52 Week LowSEK 8.00
Beta1.34
11 Month Change7.06%
3 Month Changen/a
1 Year Change95.25%
33 Year Change116.19%
5 Year Change-19.90%
Change since IPO610.00%

Recent News & Updates

Recent updates

Shareholder Returns

RSLB.FUS Healthcare ServicesUS Market
7D0%-2.0%-0.7%
1Y95.3%-0.7%32.5%

Return vs Industry: RSLB.F exceeded the US Healthcare Services industry which returned -0.7% over the past year.

Return vs Market: RSLB.F exceeded the US Market which returned 32.5% over the past year.

Price Volatility

Is RSLB.F's price volatile compared to industry and market?
RSLB.F volatility
RSLB.F Average Weekly Movementn/a
Healthcare Services Industry Average Movement9.2%
Market Average Movement6.4%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: RSLB.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine RSLB.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a411Johan Lofwww.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research.

RaySearch Laboratories AB (publ) Fundamentals Summary

How do RaySearch Laboratories's earnings and revenue compare to its market cap?
RSLB.F fundamental statistics
Market capUS$511.66m
Earnings (TTM)US$14.71m
Revenue (TTM)US$109.80m

34.8x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSLB.F income statement (TTM)
RevenueSEK 1.13b
Cost of RevenueSEK 107.48m
Gross ProfitSEK 1.02b
Other ExpensesSEK 869.89m
EarningsSEK 151.22m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 08, 2024

Earnings per share (EPS)4.41
Gross Margin90.48%
Net Profit Margin13.40%
Debt/Equity Ratio0%

How did RSLB.F perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

16%

Payout Ratio